Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry.
about
Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's diseaseIn situ drug and metabolite analysis [corrected] in biological and clinical research by MALDI MS imaging.Structural characterization of product ions by electrospray ionization and quadrupole time-of-flight mass spectrometry to support regulatory analysis of veterinary drug residues in foods. Part 2: Benzimidazoles, nitromidazoles, phenothiazines, and mCollision-induced dissociation pathways of H1-antihistamines by electrospray ionization quadrupole time-of-flight mass spectrometry.Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease.
P2860
Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of promethazine ...... LDI imaging mass spectrometry.
@en
Identification of promethazine ...... LDI imaging mass spectrometry.
@nl
type
label
Identification of promethazine ...... LDI imaging mass spectrometry.
@en
Identification of promethazine ...... LDI imaging mass spectrometry.
@nl
prefLabel
Identification of promethazine ...... LDI imaging mass spectrometry.
@en
Identification of promethazine ...... LDI imaging mass spectrometry.
@nl
P2093
P2860
P1433
P1476
Identification of promethazine ...... LDI imaging mass spectrometry.
@en
P2093
Chad W Chumbley
John C Gore
Kevin Wilson
Michelle L Reyzer
Richard A McClure
Richard M Caprioli
Wellington Pham
P2860
P304
P356
10.1016/J.NICL.2013.04.015
P577
2013-04-30T00:00:00Z